The leadership panel in the Zantac litigation was recently established, including attorneys from six law firms. This panel of lawyers will help direct the litigation against makers of the antacid drug, that include Sanofi, GlaxoSmithKline, Boehringer Ingelheim and others. Plaintiffs claim that the active ingredient in Zantac may cause patients to develop certain types of cancers. Plaintiffs filing Zantac cancer lawsuits also allege that drug makers knew Zantac and its generic ranitidine contain unacceptable levels of the carcinogen N-nitrosodimethylamine (NDMA), but continued to market and sell the drug.
While most of the cases in the litigation were consolidated in a federal multi-district litigation (MDL) in the Southern District of Florida, many others were brought in California state court in Alameda County, under what is known as a Judicial Council Coordinated Proceeding (JCCP). The JCCP in California is currently handling over 60 complaints from more than 1,000 plaintiffs. Allegations are substantially similar among cases in the Zantac MDL and the JCCP.
Do you Think You Have a Valid Cancer Claim After Taking Zantac?
Call us today at (888) 984-7988 for a confidential consultation. It’s not too late to investigate your potential Zantac cancer claim.
The next group of cases filed by women who allegedly developed ovarian cancer due to talcum powder usage are preparing for trial in 2022. The pretrial schedule order issued by the judge presiding over the centralized talc cases, The Honorable Wolfson of the District of New Jersey, indicated the first set of filing deadlines is set for December 2021. These bellwether “test” trials may help indicate how the jury will react to evidence and testimony in future trials.
Plaintiffs that filed these cases similarly allege that use of Johnson & Johnson’s talc-containing products, including Shower to Shower and Johnson’s Baby Powder, caused their ovarian cancer diagnoses. Lawsuits also allege that Johnson & Johnson neglected to warn consumers of this potentially deadly risk.
Call Today to Discuss Your Potential Talcum Powder Case
The attorneys at Grant & Eisenhofer P.A. are offering free talcum powder case evaluations. Schedule a consultation to discuss your potential case by calling us at (844) 351-2396.
After a $2.1 billion jury verdict in the Johnson & Johnson talcum powder litigation was upheld in March 2021, the drug company appealed the ruling to avoid paying the penalty. Last month, the U.S. Supreme Court denied their petition, in favor of the 22 women who claimed they developed ovarian cancer after using Johnson & Johnson talcum powder products.
Currently, there are more than 30,000 lawsuits filed by plaintiffs around the country alleging that Johnson & Johnson failed to adequately warn consumers that their talc-containing products may increase the risk for ovarian cancer and other injuries.
Contact Our Attorneys to Discuss Talcum Powder Litigation and Your Potential Case
Our team of experienced attorneys at Grant & Eisenhofer P.A. are offering free case evaluations. Schedule a consultation to discuss your potential talcum powder case by calling us at (844) 351-2396.
With over 200 cases filed against Janssen Pharmaceuticals concerning vision-related problems linked to Elmiron, plaintiffs are seeing new developments towards trial, possibly in 2023. Plaintiffs allege long-term use of the bladder-pain drug caused vision impairment symptoms, and for many, a degenerative eye disorder called “pigmentary maculopathy.” The cases were consolidated into a multi-district litigation in New Jersey, where lawyers for both plaintiffs and defendants are preparing a select few cases for trial in January 2023.
Is it Too Late to File an Elmiron Lawsuit? Call for a Free Consultation.
Cases are still being filed in the Elmiron MDL. Our experienced attorneys are investigating vision loss claims associated with the drug. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.
Leading plaintiffs law firm Grant & Eisenhofer has filed suit in California state court against Monsanto Co., maker of the herbicide Roundup, on behalf of Sacramento-area resident Michael Langford, who asserts his non-Hodgkin’s lymphoma and other cancers were caused by decades-long exposure to Roundup’s chemical ingredients, notably glyphosate.